Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 09995 REMEGEN-B > Detailed Quotes

09995 REMEGEN-B

38.050
-0.050-0.13%
Closed 09/30 16:08 CCT
High
38.900
Open
38.100
Turnover
17.68M
Low
37.500
Pre Close
38.100
Volume
465.50K
Market Cap
20.71B
P/E(TTM)
69.18
52wk High
112.600
Shares
544.26M
P/E(Static)
61.27
52wk Low
25.050
Float Cap
7.21B
Bid/Ask %
65.15%
Historical High
149.800
Shs Float
189.58M
Volume Ratio
0.24
Historical Low
25.050
Dividend TTM
--
Div Yield TTM
--
P/B
3.25
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.25%
Amplitude
3.68%
Avg Price
37.981
Lot Size
500
Float Cap
7.21B
Bid/Ask %
65.15%
Historical High
149.800
Shs Float
189.58M
Volume Ratio
0.24
Historical Low
25.050
Dividend TTM
--
P/B
3.25
Dividend LFY
--
Turnover Ratio
0.25%
Amplitude
3.68%
Avg Price
37.981
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Rongchang Biopharmaceutical (Yantai) Co., Ltd. is a Chinese company mainly engaged in R & D and manufacture of innovative biopharmaceuticals. The company specializes in the discovery, development and commercialization of therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The company's main products include RC18, RC48 and RC28. The company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The company mainly does business in the domestic market.
CEO: Weidong Wang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...